Registration Strip Icon for default 登録して無料でリアルタイムの株価、インタラクティブチャート、ライブオプションフローなどを入手してください。

OPT

Opthea (OPT)

Opthea Ltd
から:
次の項目別のソート:
 Showing the most relevant articles for your search:NASDAQ:OPT
日付受信時刻ニュースソース見出しコード企業名
2024/06/0319 : 04Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:OPTOpthea Ltd
2024/05/2819 : 05Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:OPTOpthea Ltd
2024/02/1420 : 07Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:OPTOpthea Ltd
2024/02/0120 : 04Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:OPTOpthea Ltd
2024/01/1120 : 01Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:OPTOpthea Ltd
2023/12/2720 : 01Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:OPTOpthea Ltd
2023/12/2720 : 00GlobeNewswire Inc.Opthea to Receive US$35M Commitment and Additional US$50M FundingNASDAQ:OPTOpthea Ltd
2023/12/1920 : 00GlobeNewswire Inc.Opthea Receives A$8.8 million R&D Tax IncentiveNASDAQ:OPTOpthea Ltd
2023/12/0119 : 30GlobeNewswire Inc.Opthea to Present at the FLORetina 2023 CongressNASDAQ:OPTOpthea Ltd
2023/11/0920 : 01Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:OPTOpthea Ltd
2023/11/0919 : 30GlobeNewswire Inc.Opthea to Present at the Jefferies 2023 London Healthcare ConferenceNASDAQ:OPTOpthea Ltd
2023/10/3018 : 30GlobeNewswire Inc.Opthea to Present at Eyecelerator Forum at the 2023 American Academy of Ophthalmology (AAO) ConferenceNASDAQ:OPTOpthea Ltd
2023/10/2719 : 09Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:OPTOpthea Ltd
2023/10/2719 : 06Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:OPTOpthea Ltd
2023/10/2718 : 30GlobeNewswire Inc.Opthea Appoints U.S.-Based Leadership with Fred Guerard as CEO and Peter Lang as CFONASDAQ:OPTOpthea Ltd
2023/10/0218 : 30GlobeNewswire Inc.Opthea to Participate at the 2023 Euretina CongressNASDAQ:OPTOpthea Ltd
2023/09/0719 : 04Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:OPTOpthea Ltd
2023/09/0718 : 30GlobeNewswire Inc.Opthea to Present at the H.C. Wainwright 25th Annual Global Investment ConferenceNASDAQ:OPTOpthea Ltd
2023/08/2819 : 15Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:OPTOpthea Ltd
2023/08/2818 : 30GlobeNewswire Inc.Opthea Successfully Completes Institutional Offer and Increases Capital Raising to A$90.0m (US$57.6 million¹)NASDAQ:OPTOpthea Ltd
2023/08/2419 : 16Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:OPTOpthea Ltd
2023/08/0119 : 01Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:OPTOpthea Ltd
2023/07/2619 : 00GlobeNewswire Inc.Opthea Announces “Sozinibercept” as the Nonproprietary Drug Name for OPT-302NASDAQ:OPTOpthea Ltd
2023/07/2419 : 01Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:OPTOpthea Ltd
2023/07/2419 : 00GlobeNewswire Inc.Opthea to Present at the 2023 Ophthalmology Innovation SummitNASDAQ:OPTOpthea Ltd
2023/07/1319 : 02Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:OPTOpthea Ltd
2023/07/1319 : 00GlobeNewswire Inc.Opthea to Feature at the American Society of Retina Specialists 2023 Annual MeetingNASDAQ:OPTOpthea Ltd
2023/07/1019 : 00GlobeNewswire Inc.Opthea Announces Departure of Chief Medical Officer and Appointment of Senior Medical AdvisorNASDAQ:OPTOpthea Ltd
2023/06/0819 : 03Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:OPTOpthea Ltd
2023/06/0819 : 00GlobeNewswire Inc.Opthea Appoints Anshul Thakral as Non-Executive Director of the BoardNASDAQ:OPTOpthea Ltd
 Showing the most relevant articles for your search:NASDAQ:OPT

最近閲覧した銘柄

Delayed Upgrade Clock